PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete! Earlier this month, we welcomed US-residents Merlin (23) and Kaylee (21) to their week-long trial visits at Boston Children’s Hospital. This groundbreaking trial will explore whether Progerinin, combined with the life-extending drug lonafarnib (Zokinvy), is more effective than lonafarnib alone.
For more information, click here and check back often for updates!